Prelude Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,161
Closed -$238K 1276
2023
Q3
$238K Buy
+4,161
New +$251K 0.02% 799
2020
Q4
Sell
-1,881
Closed -$69K 1806
2020
Q3
$69K Buy
1,881
+80
+4% +$2.98K ﹤0.01% 1029
2020
Q2
$68K Buy
1,801
+1,107
+160% +$44.3K ﹤0.01% 1067
2020
Q1
$25K Buy
+694
New +$27K ﹤0.01% 933
2019
Q3
Sell
-200
Closed -$6K 1956
2019
Q2
$6K Buy
+200
New +$5.94K ﹤0.01% 1502
2019
Q1
Sell
-174
Closed -$5K 2066
2018
Q4
$5K Buy
+174
New +$6.35K ﹤0.01% 1619
2017
Q3
Sell
-1,000
Closed -$53K 1834
2017
Q2
$53K Sell
1,000
-4,934
-83% -$264K 0.01% 984
2017
Q1
$330K Buy
5,934
+1,494
+34% +$82.4K 0.03% 408
2016
Q4
$231K Sell
4,440
-2,409
-35% -$116K 0.03% 529
2016
Q3
$331K Buy
6,849
+6,155
+887% +$311K 0.03% 408
2016
Q2
$38K Sell
694
-3,406
-83% -$188K 0.01% 1101
2016
Q1
$219K Hold
4,100
0.03% 524
2015
Q4
$211K Buy
4,100
+500
+14% +$24.8K 0.03% 537
2015
Q3
$163K Buy
3,600
+1,800
+100% +$85K 0.02% 676
2015
Q2
$83K Buy
1,800
+200
+13% +$8.75K 0.01% 953
2015
Q1
$69K Buy
1,600
+400
+33% +$15.2K 0.01% 1165
2014
Q4
$42K Sell
1,200
-700
-37% -$23.2K 0.01% 1326
2014
Q3
$62K Sell
1,900
-1,300
-41% -$43.5K 0.01% 1313
2014
Q2
$108K Buy
3,200
+1,900
+146% +$60.9K 0.01% 1065
2014
Q1
$35K Buy
+1,300
New +$38.6K ﹤0.01% 1476
2013
Q4
Sell
-100
Closed -$3K 1835
2013
Q3
$3K Buy
+100
New +$3.27K ﹤0.01% 1599

Other funds holding PBH

Prelude Capital Management's PBH Position: Q4 2023 in Review

Prelude Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q4 2023, closing a stake of 4,161 shares — an estimated $238K sold.

Prelude Capital Management first reported a position in PBH in Q3 2013 and held it in 21 quarters. The position peaked at $331K in Q3 2016. 288 funds tracked by Wall St. Rank hold PBH as of Q4 2023.

  • Prelude Capital Management reported no remaining Prestige Consumer Healthcare position as of Q4 2023 after selling out during the quarter.
  • Prelude Capital Management sold 4,161 Prestige Consumer Healthcare shares in Q4 2023, an estimated $238K.
  • Prelude Capital Management first reported a position in Prestige Consumer Healthcare in Q3 2013 and held it in 21 quarters.
  • Prelude Capital Management's Prestige Consumer Healthcare position peaked at $331K in Q3 2016.
  • 288 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.